Structure and function of proteins to form complex with receptor for heat-stable enterotoxin

与热稳定肠毒素受体形成复合物的蛋白质的结构和功能

基本信息

  • 批准号:
    06680583
  • 负责人:
  • 金额:
    $ 0.38万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Heat-stable enterotoxin (STs) produced by enterotoxigenic Escherichia coli are known to cause an acute diarrhea in men and animals. The biological action of ST is initiated by the binding to its receptor proteins on the membrane of intestinal epithelial cell. The formation of a ST-receptor complex leads to stimulation of guanylate cyclase and is followed by increase in cGMP concentration in the cells. Protein kinase is activated by the binding with cGMP and activate Cystic fibrosis transmembrane conductance regulator to result in a fluid secretion from the cells. In a course of study to purify receptor proteins for ST from rat intestine, receptor protein was found to form receptor protein complex. To elucidate the signal transduction mechanism by ST,it is important to know whether ST-receptor complex is the homo-oligomer or the hetero-oligomer with different proteins. Purpose of this study is to elucidate the structure and functions of proteins which forms complex with receptor protein for ST.To accomplish this purpose, ST analogs were designed to have the fluorophore, the functional group for the cross-linking to the receptor protein, and the specific binding ability to the receptor protein corresponding to that of the native ST and were synthesized. Binding characteristics of ST to the membrane prepared from rat intestine were investigated. Results revealed that membrane contained two types of receptor proteins, that is, one binds exchange-ably with ST (Rex) and the other non-echange-ably (Rnex). Rnex existed on membrane in two kinds of receptor complexes ((1) and (2)). (1) and (2) were found to be constructed with common protein components and the different component to each other. Among these proteins, analysis of common components are in progress.
产肠毒素大肠埃希菌产生的耐热肠毒素(STS)可引起人和动物的急性腹泻。ST的生物学作用是通过与肠上皮细胞膜上的ST受体蛋白结合而启动的。ST-受体复合体的形成导致鸟苷环化酶的刺激,随之而来的是细胞内cGMP浓度的增加。蛋白激酶通过与cGMP的结合而被激活,并激活囊性纤维化跨膜电导调节因子,导致细胞分泌液体。在从大鼠肠道中提纯ST受体蛋白的过程中,发现受体蛋白形成受体蛋白复合体。为了阐明ST的信号转导机制,重要的是要知道ST-受体复合体是同源低聚物还是含有不同蛋白质的异源低聚物。本研究的目的是阐明ST与受体蛋白形成复合物的蛋白质的结构和功能。为了实现这一目的,设计了ST类似物,使其具有与受体蛋白交联的荧光团和与受体蛋白的特异性结合能力,与天然ST的结合能力相当于天然ST。研究了ST与大鼠肠膜的结合特性。结果表明,膜上含有两种受体蛋白,一种与ST(Rex)可交换结合,另一种不可改变(RneX)。RneX存在于两种受体复合体(1)和(2)的膜上。(1)和(2)分别由相同的蛋白质组分和不同的蛋白质组分组成。在这些蛋白质中,对共同成分的分析正在进行中。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takashi Sato, Hiroshi Ozaki, Yasuo Hata, Yasuyuki Kitagawa, Yukiteru Katsube, and Yasutsugu Shimonishi: "Structure Chavacteristies for Biotogical Activity of Heat-Stable Entero toxin Produced by Enterotoxigenic Escherichia coli: X-ray Crystallt graphy of
Takashi Sato、Hiroshi Ozaki、Yasuo Hata、Yasuyuki Kitakawa、Yukiteru Katsube 和 Yasutsugu Shimonishi:“产肠毒素大肠杆菌产生的热稳定肠毒素的生物活性的结构特征:X 射线晶体成像
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takashi Sato, Hiroshi Ozaki, Yasuo Hata, Yasuyuki Kitagawa, Yukiteru Katsube, and Yasutsugu Shimonishi: "Structure Characteristics for Biological Activity of Heat-Stable Enterotoxin Produced by Enterotoxigenic Esherichia coli : X-ray Crystallography of We
Takashi Sato、Hiroshi Ozaki、Yasuo Hata、Yasuyuki Kitakawa、Yukiteru Katsube 和 Yasutsugu Shimonishi:“产肠毒素大肠杆菌产生的热稳定肠毒素的生物活性的结构特征:我们的 X 射线晶体学
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Sato,H.OZAKI,et al.,: "Struetural Characteristics for Biological Actinity of Heat-Stable Entaotoxin produced by Enterotoxigeric Eschoichia cali-X-ray Crystrllography of Weakly Toxic and Nontoxic Analogs" Biochemistry. 33. 8641-8650 (1994)
T.Sato、H.OZAKI 等人:“肠毒埃斯科氏菌产生的热稳定内毒素的生物活性的结构特征 - 弱毒和无毒类似物的 X 射线晶体学”生物化学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OZAKI Hiroshi其他文献

OZAKI Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OZAKI Hiroshi', 18)}}的其他基金

Studies on the phased immune-barrier systems in gut-liver axis focusing on immune responses of mesenchymal cells
肠肝轴阶段性免疫屏障系统研究,重点关注间充质细胞的免疫反应
  • 批准号:
    20228005
  • 财政年份:
    2008
  • 资助金额:
    $ 0.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Immunological approach for the molecular mechanism ofintestinal motility functions
肠蠕动功能分子机制的免疫学方法
  • 批准号:
    16208029
  • 财政年份:
    2004
  • 资助金额:
    $ 0.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Clarification of new cell signaling mediated by intermediairy metabolite of claolesterol
阐明长甾醇中间代谢物介导的新细胞信号传导
  • 批准号:
    14360176
  • 财政年份:
    2002
  • 资助金额:
    $ 0.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Intestinal motility immune systems in Hirschsprung's disease model animals
先天性巨结肠模型动物的肠道运动免疫系统
  • 批准号:
    12460132
  • 财政年份:
    2000
  • 资助金额:
    $ 0.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on novel marine bioactive substances as pharmacological resources
新型海洋生物活性物质药理资源研究
  • 批准号:
    10356011
  • 财政年份:
    1998
  • 资助金额:
    $ 0.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Organculture as a new model of atherosclerosis
器官培养作为动脉粥样硬化的新模式
  • 批准号:
    09660315
  • 财政年份:
    1997
  • 资助金额:
    $ 0.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on recognition mechanism of heat-stable enterotoxin by its receptorprotein
热稳定肠毒素受体蛋白识别机制研究
  • 批准号:
    04680160
  • 财政年份:
    1992
  • 资助金额:
    $ 0.38万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Endothelin receptor subtype and physiology of vascular smooth muscle and endothelium
内皮素受体亚型与血管平滑肌和内皮的生理学
  • 批准号:
    04454115
  • 财政年份:
    1992
  • 资助金额:
    $ 0.38万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Mechanisms underlying diarrhea and gut inflammation mediated by Enterotoxigenic and Enteropathogenic E. coli
产肠毒素和致病性大肠杆菌介导的腹泻和肠道炎症的机制
  • 批准号:
    10674072
  • 财政年份:
    2023
  • 资助金额:
    $ 0.38万
  • 项目类别:
Neuroprotection by the GUCY2C gut-brain axis in Parkinson's disease
GUCY2C 肠脑轴对帕金森病的神经保护作用
  • 批准号:
    10740951
  • 财政年份:
    2023
  • 资助金额:
    $ 0.38万
  • 项目类别:
Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis
特应性皮炎中金黄色葡萄球菌皮肤定植增强食物过敏的机制
  • 批准号:
    10638821
  • 财政年份:
    2023
  • 资助金额:
    $ 0.38万
  • 项目类别:
Targeting visceral pain through intestinal neuropod cell GUCY2C signaling
通过肠道神经足细胞 GUCY2C 信号传导治疗内脏疼痛
  • 批准号:
    10837293
  • 财政年份:
    2023
  • 资助金额:
    $ 0.38万
  • 项目类别:
Role of Rotavirus NSP4 Viroporin and Enterotoxin Activity in Aberrant Calcium Signaling and Replication
轮状病毒 NSP4 病毒孔蛋白和肠毒素活性在异常钙信号传导和复制中的作用
  • 批准号:
    10469770
  • 财政年份:
    2022
  • 资助金额:
    $ 0.38万
  • 项目类别:
Role of Rotavirus NSP4 Viroporin and Enterotoxin Activity in Aberrant Calcium Signaling and Replication
轮状病毒 NSP4 病毒孔蛋白和肠毒素活性在异常钙信号传导和复制中的作用
  • 批准号:
    10685961
  • 财政年份:
    2022
  • 资助金额:
    $ 0.38万
  • 项目类别:
Role of Macrophages in CBD mediated attenuation of SEB-induced ARDS
巨噬细胞在 CBD 介导的 SEB 诱导的 ARDS 减弱中的作用
  • 批准号:
    10867560
  • 财政年份:
    2022
  • 资助金额:
    $ 0.38万
  • 项目类别:
Legumain to the rescue: A new ADC linker strategy to address the limitations of cathepsin cleavage
Legumain 来拯救:一种新的 ADC 连接策略,解决组织蛋白酶切割的局限性
  • 批准号:
    10561636
  • 财政年份:
    2022
  • 资助金额:
    $ 0.38万
  • 项目类别:
Parkinson's disease therapies targeting GUCY2C
针对 GUCY2C 的帕金森病疗法
  • 批准号:
    10538155
  • 财政年份:
    2022
  • 资助金额:
    $ 0.38万
  • 项目类别:
Role of macrophages in CBD mediated attenuation of SEB-induced ARDS
巨噬细胞在 CBD 介导的 SEB 诱导的 ARDS 减弱中的作用
  • 批准号:
    10351483
  • 财政年份:
    2022
  • 资助金额:
    $ 0.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了